MORECELL BIOMEDICAL TECHNOLOGY DEVELOPMENT CO LTD SHENZHEN

Overview

MORECELL BIOMEDICAL TECHNOLOGY DEVELOPMENT CO LTD SHENZHEN is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering IMMUNE CELLS SERUM-FREE MEDIUM.

API / Drug Master Files

MORECELL BIOMEDICAL TECHNOLOGY DEVELOPMENT CO LTD SHENZHEN holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• IMMUNE CELLS SERUM-FREE MEDIUMActive2024-11-13

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to MORECELL BIOMEDICAL TECHNOLOGY DEVELOPMENT CO LTD SHENZHEN in our records. PharmaTek screens the full directory against live FDA enforcement data.